Intraoperative Methadone for the Prevention of Postoperative Pain

Recruiting Phase 3 Interventional Study
Orthopedic Surgery
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Supportive Care
Participants needed
80 (estimated)
Sponsor
Brugmann University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The pain felt after orthopedic surgery in the absence of adequate locoregional anesthesia is often insufficiently controlled, especially during the first 24 hours postoperatively. Methadone, due to its long half-life, may provide better pain control after orthopedic surgery when associated locoregional anesthesia cannot be performed. It may be impossible to perform loco-regional anesthesia in va…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age between 18 and 80 years old * ASA 1-3 status * Elective partial or total hip and knee arthroplasty Exclusion Criteria: * Patient refusal * Preoperative renal failure (serum creatinine \> 2 mg/dL or 1.5-fold * Increase in basal plasma creatinine or GFR \< 90 ml/min/1.73m2…
Contacts

Riccardo Mora, MD

00393292199132

riccardo.mora@chu-brugmann.be

CONTACT